Non-patent literature search at the European Patent Office
Sign Up to like & getrecommendations! Published in 2018 at "World Patent Information"
DOI: 10.1016/j.wpi.2017.07.001
Abstract: Abstract On average, one out of five search reports issued by the European Patent Office (EPO) contains a non-patent literature (NPL) document citation, mainly from scholarly papers. More than half of all search reports in… read more here.
Keywords: search; patent office; european patent; non patent ... See more keywords
The intriguing role of USP30 inhibitors as deubiquitinating enzymes from the patent literature since 2013.
Sign Up to like & getrecommendations! Published in 2021 at "Expert opinion on therapeutic patents"
DOI: 10.1080/13543776.2022.2003780
Abstract: INTRODUCTION : Ubiquitin specific peptidase 30 (USP30) is a mitochondrial deubiquitinase that antagonizes ubiquitination-mediated mitophagy of damaged or impaired mitochondria driven by the activity of PARK2/Parkin ubiquitin ligase and PINK1 protein kinase. Researchers have related… read more here.
Keywords: usp30 inhibitors; small molecule; since 2013; patent literature ... See more keywords
A patent and literature review of CDK12 inhibitors
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2022.2126765
Abstract: ABSTRACT Introduction Cyclin-dependent kinase 12 (CDK12) belongs to the CDK family of serine/threonine protein kinases and is associated with cyclin K to exert its biological functions, including regulating gene transcription, mRNA processing, and translation. Increasing… read more here.
Keywords: cdk12; patent literature; literature review; cdk12 inhibitors ... See more keywords
Receptor-interacting protein kinase 1 (RIPK1) inhibitor: a review of the patent literature (2018-present)
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2023.2195548
Abstract: ABSTRACT Introduction RIPK1 is a critical mediator of inflammation and cell death, which is associated with extensive neurodegenerative and inflammatory diseases. Recently, RIPK1 has aroused the interests of pharmaceutical industry and research institutions. Areas covered… read more here.
Keywords: receptor interacting; review; ripk1 inhibitors; ripk1 ... See more keywords
The Discovery and Development of Drug Combinations for the Treatment of Various Diseases from Patent Literature (1980-Present).
Sign Up to like & getrecommendations! Published in 2017 at "Current topics in medicinal chemistry"
DOI: 10.2174/1568026616666160818152257
Abstract: The search for a miracle drug that would help to alleviate multiple ailments, dates back many thousands of years before our era and continues until today. Various techniques have been used to obtain a formulation,… read more here.
Keywords: treatment various; treatment; drug; patent literature ... See more keywords
The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature
Sign Up to like & getrecommendations! Published in 2022 at "Antioxidants"
DOI: 10.3390/antiox11050876
Abstract: Quercetin is a phenolic flavonol compound with established antioxidant, anti-inflammatory, and immuno-stimulant properties. Recent studies demonstrate the potential of quercetin against COVID-19. This article highlighted the prophylactic/therapeutic potential of quercetin against COVID-19 in view of… read more here.
Keywords: potential quercetin; quercetin covid; clinical studies; patent literature ... See more keywords
Development of Therapeutic and Prophylactic Zinc Compositions for Use against COVID-19: A Glimpse of the Trends, Inventions, and Patents
Sign Up to like & getrecommendations! Published in 2022 at "Nutrients"
DOI: 10.3390/nu14061227
Abstract: Zinc is an essential nutrient for human health; it is involved in the catalytic, structural, and regulatory functions of the human cellular system. Different compositions of zinc, as well as its pharmaceutically acceptable salts, are… read more here.
Keywords: zinc; patent literature; trends inventions; zinc compositions ... See more keywords
A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak
Sign Up to like & getrecommendations! Published in 2022 at "Viruses"
DOI: 10.3390/v14091870
Abstract: Monkeypox disease (MPX) is currently considered a global threat after COVID-19. European Medicines Agency (EMA) approved Tecovirimat in capsule dosage form (200 mg) as the first treatment for MPX in January 2022. This article highlights… read more here.
Keywords: drug; patent literature; development patent; tecovirimat ... See more keywords